Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary revascularization products, such as balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty; intraluminal ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides cardiac rhythm management devices consisting of implantable cardioverter defibrillator, and implantable pacemaker systems that monitor the heart and deliver electricity to treat cardiac abnormalities; endoscopy products, such as devices to treat diseases of the digestive and pulmonary systems; and peripheral interventions to treat patients with peripheral diseases. In addition, the company offers devices comprising mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices to treat urinary stone disease, stress urinary incontinence, pelvic organ prolapse, and excessive uterine bleeding. Further, it provides neuromodulation products used for the management of chronic pain; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, such as frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Additionally, it offers implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; and implantable pacemaker systems used to manage slow or irregular heart rhythms. The company was founded in 1979 and is headquartered in Natick, Massachusetts.